NCT00523926View on ClinicalTrials.gov

TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

October 31, 2005

Conditions
Tuberculosis
Interventions
DRUG

TMC207

All Listed Sponsors
lead

Tibotec BVBA

INDUSTRY

NCT00523926 - TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis | Biotech Hunter | Biotech Hunter